New biomarker can predict cancer aggressiveness, study finds

Don Thomas’s “secret weapons”—and how a 1970s BMT database continues to lead to new findings

In the 1970s, when E. Donnall Thomas was researching bone marrow transplantation, Fred Hutchinson Cancer Center started a database of transplant recipients.

April 11, 2025

Vol.51 No.14

In Brief

Filippo Milano named inaugural Endowed Chair in Cord Blood Research at Fred Hutch

Filippo Milano, a hematologist-oncologist and clinical researcher, was named the inaugural Endowed Chair in Cord Blood Research at Fred Hutchinson Cancer Center.

April 11, 2025

Vol.51 No.14

In Brief

Casirati, De Wolf, Persaud, Rehman awarded $260,000 research grants from DKMS

Gabriele Casirati, of Boston Children’s Hospital, Susan E. De Wolf, of Memorial Sloan Kettering Cancer Center, Stephen Persaud, of Washington University School of Medicine, and Abdur Rehman, of the University of Texas MD Anderson Cancer Center, were awarded DKMS’ research grant in honor of John A. Hansen.

April 11, 2025

Vol.51 No.14

Clinical Roundup

NK cells complexed with bispecific antibody yield high response rates in lymphoma

A novel cell therapy approach using cord blood-derived natural killer cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates for patients with refractory CD30-positive lymphomas, according to a new study from the University of Texas MD Anderson Cancer Center.

April 11, 2025

Vol.51 No.14

In Brief

MD Anderson breaks ground on new Houston-area cancer center

The University of Texas MD Anderson Cancer Center on March 31 broke ground on a new 470,000-square-foot facility in Sugar Land, bringing a range of cancer services closer to those living in Southwest Houston and the surrounding areas.

April 04, 2025

Vol.51 No.13